Topic: translational medicine

Chemistry and neuroscience meet in a French-language programme on brain disorders and treatments. Topics include delivering drugs to the brain, obstacles in neurodegenerative therapy, translational medicine, marine natural products, exposure biomarkers and lysosomal approaches. Afternoon research addresses membranes in Alzheimer’s disease, copper chelators, multifunctional molecules and natural products, followed by a lecture on memory. The programme runs 09:00–17:00 Paris time on 4 November. In-person attendance is free with advance registration by 25 October; lunch depends on capacity, with

Technological advances have made Gene therapy a promising therapeutic strategy for a wide range of neurodegenerative diseases. Adeno-associated viruses (AAVs) have demonstrated significant potential as safe and effective vectors for the delivery of therapeutic genes to the CNS. Despite the tremendous promises of AAV-based gene therapies, the pathway to develop these therapies from bench to clinic remains complex and arduous. In response to these challenges, we introduce the BrainVector project, a comprehensive cross-disciplinary platform that streamlines the pre-clinical development of AAV-bas